|
Delayed
Nasdaq
01:46:28 11/11/26 am AEDT
|
5-day change | 1st Jan Change | ||
| 7.580 USD | -0.66% |
|
-11.55% | -2.82% |
| 05/11 | BioCryst Pharmaceuticals, Inc., Q3 2026 Earnings Call, Nov 04, 2026 | |
| 05/11 | Wedbush Adjusts BioCryst Pharmaceuticals PT to $17 From $18, Maintains Outperform Rating | MT |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -0.66% | -11.55% | -9.33% | -22.97% | -2.82% | +5.28% | +52.21% | -40.46% | +49.51% | 1.96B | |
| +0.01% | +8.40% | -4.75% | -2.92% | +65.82% | +58.48% | +69.01% | +18.37% | - | 68.22B | |
| +1.57% | +9.99% | +18.33% | +13.12% | +21.04% | +16.43% | +90.98% | +223.25% | +6,168.79% | 59.82B | |
| -0.09% | +0.95% | +14.70% | +13.60% | +22.42% | +23.30% | +96.77% | -9.78% | +263.15% | 56.07B | |
| +0.75% | +17.82% | +19.37% | +16.51% | +37.67% | +27.05% | +110.06% | +13.66% | +1,064.41% | 47.67B | |
| -0.87% | +4.77% | +4.92% | +13.69% | +22.05% | +29.13% | +40.38% | +9.12% | +251.17% | 45.95B | |
| -1.10% | +1.05% | +1.19% | -5.17% | +146.40% | +212.86% | +895.74% | +519.12% | - | 43.29B | |
| -0.47% | +9.38% | +16.93% | +5.37% | +21.82% | +27.53% | +52.40% | +24.29% | +192.98% | 35.66B | |
| -0.19% | -2.10% | +46.40% | +82.78% | +79.63% | +94.13% | +69.11% | +31.02% | +200.66% | 34.73B | |
| +1.96% | +11.76% | +18.43% | -13.38% | -32.93% | -39.18% | +391.45% | +270.54% | +721.39% | 25.47B | |
| +1.43% | +15.23% | -5.75% | +7.59% | +57.82% | +45.26% | +1.58% | -52.29% | - | 25.6B | |
| +0.27% | +0.83% | -8.55% | -5.56% | -7.94% | -16.59% | -11.97% | -62.77% | - | 21.7B | |
| -0.81% | +1.01% | +8.09% | +11.25% | +19.33% | +11.62% | +143.39% | +206.03% | +1,845.43% | 18.82B | |
| -1.21% | -0.91% | +19.78% | +35.29% | +63.47% | +73.03% | +241.19% | +290.68% | +355.21% | 17.51B | |
| +0.69% | +0.69% | +13.11% | +25.41% | +40.77% | +51.45% | +76.85% | -13.15% | +116.65% | 16.69B | |
| -0.38% | +2.92% | +13.43% | +0.73% | - | - | - | - | - | 17.07B | |
| -1.71% | -2.22% | +13.98% | +24.21% | +72.48% | +103.63% | +100.05% | -11.23% | +356.51% | 16.93B | |
| -6.57% | +7.56% | +7.11% | +3.23% | +202.10% | +183.41% | +320.74% | +1,489.99% | +849.20% | 17.29B | |
| -2.31% | -0.03% | +23.91% | +22.68% | +11.79% | +29.19% | -20.53% | -25.51% | +147.70% | 15.55B | |
| -2.31% | +6.22% | +21.55% | +50.09% | +39.95% | +15.13% | - | - | - | 15.4B | |
| Average | -0.51% | +4.14% | +11.64% | +13.78% | +46.36% | +50.06% | +151.08% | +160.05% | +898.77% | 30B | |
| Weighted average by Cap. | -0.21% | +5.37% | +11.87% | +13.55% | +47.64% | +51.60% | +159.42% | +136.36% | +1,327.12% |
- Stock Market
- Stocks
- BCRX Stock
- Sector BioCryst Pharmaceuticals, Inc.
Select your edition
All financial news and data tailored to specific country editions
